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Abstract Patients in intensive care units (ICUs) frequently
have multiple infections or persistent fever despite man-
agement. The aim of this study was to evaluate the diag-
nostic contribution of gallium-67 scintigraphy in ICU
patients with suspected occult sepsis. One hundred and
seventeen patients ([18 years) who had undergone gallium-
67 scintigraphy in the ICU of our medical center over a
3-year period were retrospectively reviewed and analyzed.
Patients were categorized into Group 1 (n = 84), those with
a known infectious source, but who still had persistent fever
or sepsis despite antibiotic treatment or abscess drainage; or
Group 2 (n = 33), those without an evident infectious
source after clinical, physical, and imaging studies. Among
the 117 patients, 19 (16.2%) had a new diagnosis. In Group
1, 12 patients (14%) had a new infection, including pneu-
monia (4 patients), bed sore infection (2 patients),
pulmonary tuberculosis (2 patients), leg cellulitis (1 patient),
psoas muscle abscess (1 patient), osteomyelitis (1 patient),
and infective endocarditis (1 patient). In Group 2, seven
patients (21.2%) had a new infectious source, including
septic arthritis (3 patients), osteomyelitis (2 patients), neck
abscess (1 patient), and cholecystitis (1 patient). Significant
differences were not observed between patients with posi-
tive and negative findings on gallium-67 scintigraphy in
characteristics, underlying diseases, laboratory data, and
outcomes. Gallium-67 scintigraphy helped to detect new or
additional infectious sites, particularly bone, joint, and soft
tissues. However, differences in hospital stay and mortality
were not observed between patients with positive and neg-
ative findings.
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Abbreviations
ICU Intensive care unit
67Ga Gallium-67
AST Aspartate aminotransferase
LOS Length of stay
BUN Blood urea nitrogen
APACHE Acute physiology and chronic health
evaluation
GCS Glasgow coma scale
Introduction
Despite the advances in diagnostic modalities and antibi-
otics, sepsis remains a critical problem with high morbidity
and mortality in the intensive care unit (ICU) [1]. Identi-
fication of an infectious source in septic patients is usually
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based on clinical, biochemical, and microbiologic data and
radiologic imaging. The most common infectious sources
in the ICU are pneumonia, urinary tract infections, blood-
stream infections, surgical site infections, and catheter-
related infections [2–5]. However, in a few cases, the site
of infection is difficult to determine, and is thus defined as
occult sepsis [6, 7]. In addition, ICU patients frequently
have multiple infections and non-infectious causes of fever
[3, 8], and these may increase the complexity of the
diagnosis of infection. Thus, a systematic and compre-
hensive diagnostic tool to solve this problem is needed.
Nuclear medicine has played an important role in the
evaluation of patients suspected of harboring infection for
decades, including the use of 99mTc-methylene diphospho-
nate (MDP), 67Gallium-citrate (67Ga), and 111In-oxine- and
99mTc-hexamethylpropyleneamine oxime (HMPAO)-labe-
led autologous leukocytes [2, 9, 10]. However, studies
investigating the application of nuclear medicine to fever of
unknown origin or occult sepsis in critically ill patients are
limited [6, 7, 11]. 67Gascintigraphy has been used for
localizing infections for more than three decades. The
radionuclide, 67Ga, emits four principal gamma-rays suit-
able for imaging: 93, 184, 296, and 388 keV. About 90% of
circulating 67Ga is in the plasma, and nearly all of it is bound
to transferrin. Increased blood flow and increased vascular
membrane permeability result in increased delivery and
accumulation of transferrin-bound 67Ga at inflammatory
foci. In addition, 67Ga also binds to lactoferrin and leuko-
cytes, which are present in high concentrations in inflam-
matory foci [2]. Several studies prove that 67Ga scanning is
clinically effective in the localization of infectious sources
[12–17]. Among these studies, only one used 67Ga scans to
detect sources of fever in ventilated, critically ill patients
[14]. However, the sample size of that study was relatively
small, and characteristically focused on ventilated patients,
and those with acute respiratory distress syndrome (ARDS).
Infections in the ICU are usually complicated and crit-
ical, necessitating prompt diagnosis and management. In
our clinical practice, 67Ga scans are usually suggested by
infectious disease specialists or intensivists if a critically ill
patient has suspected occult sepsis or persistent fever of
unknown origin. The aim of this study was to evaluate the
diagnostic contribution of 67Gascintigraphy in patients with
occult sepsis in our medical ICU.
Materials and methods
Enrolled patients
We retrospectively reviewed the charts and associated
medical information of all patients ([18 years) who had
undergone 67Ga inflammation scanning in our medical ICU
from January 2003 to December 2006. Our hospital, China
Medical University Hospital (CMUH), is a university-
affiliated, 2,000-bed (40-bed medical ICU) tertiary medical
center in Taiwan. All intensivists in our medical ICU are
certified by the Taiwan Society of Pulmonary and Critical
Care Medicine.
In our clinical practice, patients who have a fever of
unknown origin or occult sepsis (suspected infection with
systemic inflammatory response syndrome), despite exten-
sive diagnostic workup, can be further examined by 67Ga
scanning. An extensive diagnostic workup, including care-
ful history taking, physical examination, microbiological,
and serological data, plain radiography, ultrasonography,
and computed tomography (CT), was done for most of the
patients as routine practice by our ICU doctors and infection
specialists. During the 3-year period, 123 critically ill
patients had 67Ga scans, and 6 of these patients were
excluded because of missing data or incomplete diagnostic
workup prior to 67Ga scanning. The study was approved
by the Institutional Review Board of the China Medical
University Hospital (CMUH).
Gallium-67 scintigraphy
Total body imaging was conducted 24–72 h after intrave-
nous injection of 3–6 mCi of 67Ga citrate. Planar scintig-
raphy was performed with a dual-head, variable-angle
digital c-camera with a medium-energy collimator at the
three main energy peaks of 67Ga: 93, 184, and 300 keV.
For routine survey studies, imaging was usually carried out
at 1 and 3 days post-injection. The day 1 study was rarely
definitive and served as a baseline to help distinguish
physiologic bowel activity in abdominal scans from path-
ologic activity [11]. All patients underwent bowel prepa-
ration the evening before the scan in order to reduce the
normal accumulation of 67Ga in the colon. The normal
biodistribution of 67Ga, which can be variable, includes the
bone, bone marrow, liver, genitourinary and gastrointesti-
nal systems, and soft tissues. The results of the67Ga scans
were interpreted by the staff of the Department of Nuclear
Medicine of CMUH, and were judged to be normal if no
accumulation of gallium was detected except at the sites of
physiological uptake. If a patient had a positive finding in
the 67Ga scan, we consulted a specialist to confirm the
diagnosis and to prescribe further management strategies.
Data collection and definitions
We analyzed the following clinical and laboratory param-
eters: age, gender, body mass index, clinical features,
Glasgow Coma Scale (GCS), underlying diseases, causes
of admission, Acute Physiology and Chronic Health
Evaluation (APACHE) II score, complete blood counts,
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biochemistry data, bacteriology, occurrence of complica-
tions, and duration of ICU stay and outcomes. Sepsis and
septic shock were defined in accordance with the criteria of
the International Sepsis Definitions Conference [18].
Respiratory failure was defined as the requirement of
mechanical ventilation support according to the judgment
of the clinical physicians and disease progress.
Because of the probability of multiple infections in
critically ill patients, the patient population was divided
into two groups: Group 1, patients with a pre-existing
infectious site (those with a known infectious source, but
who still had persistent fever or sepsis despite antibiotic
treatment or abscess drainage); or Group 2, patients with-
out a pre-existing infectious site (those without an evident
infectious source after thorough clinical, physical, and
imaging studies). After performing the 67Ga scans, patients
in Group 2 were further divided into new diagnosis and
negative findings groups according to clinical judgment
and the results of the scans. Patients with new diagnosis
were those who had a newly discovered infectious source.
Similarly, patients in Group 1 were further divided into
three groups: new diagnosis, confirmed infection, and
negative findings. Confirmed infection was diagnosed if the
infectious source detected by the 67Ga scan was the same
as the source already known in patients with a pre-existing
infectious site.
Statistical analysis
The data were compiled and analyzed using commercial
statistical software (SPSS for Windows, version 13.0,
Chicago, IL, USA). All continuous data were expressed as
mean ± standard deviation (SD) and compared using a
two-tailed Student’s t test. Categorical variables were
reported as a percentage and compared using chi-square or
Fisher’s exact tests, when appropriate. A p value\0.05 was
considered statistically significant.
Results
Patient characteristics
The 117 enrolled patients included 64 men (54.7%) and 53
women (45.3%), with a mean age of 68.2 years (range
22–90 years). The most common concomitant underlying
disease was diabetes mellitus (n = 50, 42.7%), followed
by hypertension (n = 47, 40.2%), stroke (n = 25, 21.4%),
and end-stage renal disease (n = 21, 17.9%) (Table 1).
The mean APACHE II score was 18.7 ± 7, and 77 (65.8%)
patients had respiratory failure requiring mechanical ven-
tilation on the first day of ICU admission. The most com-
mon diagnosis at admission was fever of unknown origin
(n = 27, 23.1%), followed by neurogenic/cerebrovascular
disorder (n = 17, 14.5%), pneumonia or pleural infection
(n = 15, 12.8%), urinary tract infection (n = 13, 11.1%),
and cardiovascular disorder (n = 10, 8.5%) (Table 2).
Diagnostic evaluation
Among the 117 patients who underwent 67Gascintigraphy,
19 (16.2%) were found to have a new diagnosis. Because
of the complexity of infections in critically ill patients, we
further divided them into two groups (Fig. 1). Eighty-four
patients had a pre-existing infectious site (Group 1), and 33
Table 1 Characteristics of the 117 enrolled patients on the first day
of ICU admission
Characteristics Value
Age 68.2 ± 13.8 (22–90)
Gender, male/female 64/53 (54.7%/45.3%)
Body mass index, kg/m2 22.9 ± 3.8 (15.5–35.3)
Underlying diseases
Diabetes mellitus 50 (42.7%)
Hypertension 47 (40.2%)
Stroke 25 (21.4%)
End-stage renal disease 21 (17.9%)
Malignancy 8 (6.8%)
Liver cirrhosis 4 (3.4%)
APACHE II 18.7 ± 7 (12–36)
GCS 9.8 ± 3 (3–15)
Vasopressor use 64 (54.7%)
Respiratory failure 77 (65.8%)
APACHE acute physiology and chronic health evaluation, GCS glasgow
coma scale
Table 2 Categories of diagnosis at admission among the 117 patients
Diagnosis n (%)
Sepsis of unknown origin 27 (23.1)
Neurogenic disorder 17 (14.5)
Pneumonia or pleural infection 15 (12.8)
Urinary tract infection 13 (11.1)
Cardiovascular disorder 10 (8.5)
Bone or soft tissue infection 8 (6.8)
Metabolic disorder 5 (4.3)
Intra-abdominal infection 4 (3.4)
Drug overdose 4 (3.4)
Malignancy-related complication 3 (2.6)
Hepatic failure 2 (1.7)
Gastrointestinal bleeding 2 (1.7)
Catheter-related infection 2 (1.7)
Acute renal failure 2 (1.7)
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did not have a pre-existing infectious site (Group 2). After
performing 67Ga scans, seven patients (21.2%) in Group 2
were found to have a new infectious source, including
septic arthritis (n = 3), osteomyelitis (n = 2), neck abscess
(n = 1), and cholecystitis (n = 1). In Group 1, 12 patients
(14.3%) were found to have a new infectious source
including pneumonia (n = 4), bed sore infection (n = 2),
pulmonary tuberculosis (n = 2), leg cellulitis (n = 1),
psoas muscle abscess (n = 1), osteomyelitis (n = 1), and
infective endocarditis (n = 1). Thirty-seven patients (44%)
were confirmed to have the same infectious source as that
known before the test, and 35 patients (41.7%) had nega-
tive findings. All 19 patients with a newly diagnosed
infectious source under went further sepsis management,
including treatment with new antibiotics, abscess drainage,
debridement of bed sores, and surgery.
Effect of 67Ga scanning
Comparing the clinical features and outcomes of Group 2
patients, there were no significant differences between
patients with positive and negative findings on the 67Ga
scans in general characteristics, underlying diseases, labo-
ratory data, and outcomes. However, there were trends of
higher serum C-reactive protein levels (20.34 ± 14.48 vs.
10.01 ± 9.79 mg/dl, p = 0.077) and in-hospital mortality
rates (71.4 vs. 26.9%, p = 0.071) in patients with positive
findings on 67Ga scans (Table 3).
Comparing the clinical features and outcomes of Group
1 patients, there were no significant differences between
the patients with positive and negative findings on the 67Ga
scans in general characteristics, underlying diseases, labo-
ratory data, and outcomes (Table 4).
Discussion
We found that 67Ga scintigraphy was helpful in detecting new
or additional infectious sites in 21.2% of patients without a
pre-existing infectious site and 58.3% of patients with a pre-
existing infectious site. Among the newly diagnosed infec-
tions (n = 19), the most common sources detected by the
scans were bone/joint infections (n = 6, 31.5%) and soft tis-
sue infections (n = 5, 26.3%). Comparing the clinical fea-
tures and outcome of these patients further, we found no
significant differences between patients with positive and
negative findings on the 67Ga scans in general characteristics,
underlying diseases, laboratory data, and outcomes.
67Ga scintigraphy has been used as a screening procedure to
detect areas of inflammation or infection for decades.
Although it lacks specificity, its sensitivity is high in detecting
infections, abscesses, and some neoplasms. Because of these
characteristics, it has been used as a convenient imaging tool
to help in the evaluation of cases of fever of unknown origin
[11], even though there are certain drawbacks. The major
drawbacks are that localization of abdominal infections is
hampered by normal bowel excretion and unfavorable phys-
ical characteristics on c-camera imaging [19]. However, this is
easily overcome by the complementary role of abdominal CT.
Almost all abdominal infectious and inflammatory processes
can be diagnosed in their early stages by abdominal CT.
Surprisingly, the most common newly diagnosed
infections detected by the scans were bone/joint infections
(31.5%) and soft tissue infections (26.3%). This is probably
because most intensivists rely on CT or ultrasonography as
their screening tool for patients with suspected occult
sepsis. CT and ultrasonography have a limited ability in
diagnosing bone or joint infection.
Fig. 1 Flow chart of the 117
patients with occult sepsis who
underwent gallium-67 scans in
the medical ICU
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Table 3 Comparison of the
clinical features and outcomes
between positive and negative
findings on gallium scans in the
33 occult sepsis patients without
pre-existing infectious sites
ICU intensive care unit, AST
aspartate aminotransferase, LOS
length of stay, BUN blood urea
nitrogen, APACHE acute
physiology and chronic health
evaluation
Clinical feature Gallium scan
positive (n = 7)
Gallium scan
negative (n = 26)
p value
Age 68.57 ± 13.30 65.19 ± 18.45 0.665
GCS 11.71 ± 2.63 9.38 ± 3.84 0.142
APACHE II score 21.14 ± 8.36 18.27 ± 7.54 0.388
Shock 1 (14.3%) 16 (61.5%) 0.039
Acute respiratory failure 3 (42.9%) 19 (73.1%) 0.186
Underlying diseases
Diabetes mellitus 3 (42.9%) 8 (30.8%) 0.661
Liver cirrhosis 0 (0%) 1 (3.8%) 1.000
End-stage renal disease 7 (14.3%) 7 (20%) 0.559
Stroke 0 (0%) 8 (30.8%) 0.154
Laboratory data
WBC count (103/per mm3) 13.222 ± 4.422 17.313 ± 8.375 0.227
Hemoglobin (g/dl) 9.157 ± 2.000 10.513 ± 3.468 0.333
Platelet (103/per mm3) 185.286 ± 87.410 211.088 ± 129.392 0.624
AST (IU/l) 84.00 ± 92.73 69.25 ± 80.10 0.732
BUN (mg/dl) 73.33 ± 40.63 42.15 ± 31.89 0.060
Albumin (g/dl) 1.70 ± 0.69 2.76 ± 0.98 0.107
C-reactive protein (mg/dl) 20.34 ± 14.48 10.01 ± 9.79 0.077
Outcome
LOS in ICU, days 26.14 ± 13.87 44.38 ± 81.12 0.563
Total LOS, days 47.57 ± 38.39 94.23 ± 125.50 0.344
In-hospital mortality 5 (71.4%) 7 (26.9%) 0.071
Table 4 Comparison of clinical
features and outcomes between
positive and negative findings
on gallium scans in the 84
occult sepsis patients with pre-
existing infectious sites
ICU intensive care unit,
APACHE acute physiology and
chronic health evaluation, LOS
length of stay
Clinical feature Gallium scan
positive (n = 49)
Gallium scan negative
(n = 35)
p value
Age 68.41 ± 12.65 70.06 ± 11.84 0.547
GCS 10.10 ± 3.47 9.49 ± 3.98 0.453
APACHE II score 17.43 ± 6.66 20.46 ± 7.00 0.067
Shock 26 (53.1%) 21 (60.0%) 0.652
Acute respiratory failure 36 (73.5%) 24 (68.6%) 0.634
Underlying diseases
Diabetes mellitus 24 (49%) 15 (42.9%) 0.660
Liver cirrhosis 1 (2.0%) 2 (5.7%) 0.568
End-stage renal disease 7 (14.3%) 7 (20%) 0.559
Stroke 10 (20.4%) 7 (20%) 1.000
Malignancy 3 (6.1%) 4 (11.4) 0.443
Laboratory data
WBC count (103/per mm3) 13.851 ± 8.066 14.163 ± 6.675 0.855
Hemoglobin (g/dl) 10.62 ± 2.26 10.61 ± 2.27 0.968
Platelet (103/per mm3) 167.577 ± 102.05 194.333 ± 129.066 0.310
AST (IU/l) 86.65 ± 294.06 121.54 ± 347.64 0.669
BUN (mg/dl) 46.33 ± 33.92 47.16 ± 30.18 0.914
Albumin (g/dl) 2.23 ± 0.66 2.35 ± 0.60 0.547
C-reactive protein (mg/dl) 16.72 ± 12.54 13.48 ± 9.35 0.320
Outcome
LOS in ICU, days 25.39 ± 13.87 22.03 ± 12.02 0.251
Total LOS, days 63.82 ± 70.20 84.46 ± 112.36 0.304
In-hospital mortality 15 (30.6%) 15 (42.9%) 0.260
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Identification of fever sources is difficult in the ICU
because critically ill patients frequently have multiple
infections. In addition, some microorganisms, such as
Klebsiella pneumoniae and Staphylococcus aureus have the
potential to cause metastatic infection, and some may require
surgical intervention [20]. Another type of nuclear medicine,
F-18-fluorodeoxyglucose positron emission tomography/
computed tomography (18F-FDG PET/CT), also plays an
important role in localizing these disseminating infectious
processes [21, 22]. However, performing 18F-FDG PET/CT
is quite expensive, and is not supported by the health insur-
ance system in Taiwan. As a result, we routinely use 67Ga
scintigraphy to detect suspected occult sepsis in patients with
pre-existing infections when they have persistent fever or
systemic inflammatory response syndrome despite antibiotic
and medical management. In our study, we found that the
infectious source was confirmed in 44% of patients with pre-
existing infections. This is helpful for intensivists because it
can guide their clinical judgment and treatment strategies.
There are some limitations to our study. First, it took
2–3 days to complete the 67Ga study. This delay may in turn
result in delayed treatment of the sepsis in some cases.
Second, the final diagnosis in negative 67Ga scintigraphy
findings may be underestimated because of the sensitivity of
the test. Third, it is a retrospective study, and the time point
for performing the scans was not the same for all enrolled
patients. However, all the patients had fever or suspected
occult sepsis despite thorough studies and standard man-
agement. As a result, our study can offer clinical intensivists
a method of dealing with this problem when it occurs.
Fever or infection control in the ICU is a critical issue
despite the improvement of biochemical and imaging
techniques. Our study showed that 67Ga scintigraphy helped
in detecting new or other infectious sites, particularly
bone, joint, and soft tissue. However, no differences were
observed in hospital stay and mortality between patients
with positive and negative findings on 67Gascintigraphy.
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